S'abonner

Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease - 18/07/22

Doi : 10.1016/j.diabet.2022.101377 
Xinxia Chang 1, 2, #, Hua Bian 1, 2, #, Mingfeng Xia 1, 2, Xiaopeng Zhu 1, 2, Xiaoyang Sun 1, 2, Xinyu Yang 1, 2, Jian Gao 3, 4, , Huandong Lin 1, 2, , Hongmei Yan 1, 2, , Xin Gao 1, 2
1 Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, 200032, China 
2 Fudan Institute for Metabolic Diseases, Fudan University, Shanghai 200032, China 
3 Center of Clinical Epidemiology and Evidence-based Medicine, Fudan University, Shanghai 200032, China 
4 Department of Nutrition, Zhongshan Hospital, Fudan University, Shanghai, 200032, China 

Address of correspondence: Dr Hongmei Yan, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Fudan Institute for Metabolic Diseases, Fudan University, Shanghai 200032, China.Department of Endocrinology and MetabolismZhongshan Hospital, Fudan University, Shanghai, 200032, China. Fudan Institute for Metabolic Diseases, Fudan UniversityShanghai200032China⁎⁎Co-correspondence: Prof. Huandong Lin, Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. Fudan Institute for Metabolic Diseases, Fudan University, Shanghai 200032, ChinaDepartment of Endocrinology and MetabolismZhongshan Hospital, Fudan University, Shanghai, 200032, China. Fudan Institute for Metabolic Diseases, Fudan UniversityShanghai200032China⁎⁎⁎Co-correspondence: Dr Gao Jian, Center of Clinical Epidemiology and Evidence-based Medicine of Fudan University, Shanghai 200032, China; Department of clinical nutrition, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.Center of Clinical Epidemiology and Evidence-based Medicine of Fudan University, Shanghai 200032, China; Department of clinical nutrition, Zhongshan Hospital, Fudan UniversityShanghai200032China
Sous presse. Manuscrit accepté. Disponible en ligne depuis le Monday 18 July 2022
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder

Abstract

Aim

Type 2 diabetes (T2DM) is closely related to nonalcoholic fatty liver disease (NAFLD) and is an important risk factor for the progression of liver fibrosis, but the role of 2-h postprandial blood glucose (PPG) as a biomarker in this process remains unclear. This study was designed to investigate the relationship between PPG and liver fibrosis in Chinese NAFLD populations with or without T2DM.

Methods

This study included three independent NAFLD populations:1) 618 inpatients with T2DM or pre-diabetes, 2) 255 patients with T2DM or pre-diabetes who underwent liver biopsy, and 3) a prospective community-based cohort without diabetes who completed a median of 4.22 years follow-up. The degree of liver fibrosis was assessed by liver fibrosis stage in subjects with a liver biopsy, and by NAFLD fibrosis score (NFS) in subjects without liver biopsy.

Results

In the first population, PPG {OR 0.02, [95% CI (0.01-0.03)], P< 0.0001} was positively correlated with NFS. In the second population, an increasing PPG was associated with increase in the proportion of advanced liver fibrosis (P = 0.012). Multivariate line regression revealed that PPG {OR 0.03 [95% CI (0.00-0.06)], P = 0.049}was positively associated with liver fibrosis stages. In the third population, PPG {OR 0.103, [95% CI (0.011-0.194) P = 0.028} at baseline was positively associated with NFS at follow-up. Furthermore, changes in PPG were significantly associated with NFS change after follow-up. We did not find a similar association between fasting glucose or HbA1c and liver fibrosis.

Conclusions

PPG was independently associated with the severity of liver fibrosis in the Chinese NAFLD population.

Le texte complet de cet article est disponible en PDF.

Keywords : 2-h postprandial blood glucose, Type 2 diabetes, Nonalcoholic fatty liver disease, Liver fibrosis


Plan


© 2022  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.